Mucosa-associated Lymphoid Tissue Lymphoma
📧 Sign up to get email alerts when something new happens for Mucosa-associated Lymphoid Tissue Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma [Phase 2]
Phase 2 trial evaluating Orelabrutinib followed by response-adapted ultra-low-dose 4 Gy radiation as first-line therapy for mucosa-associate…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT) [Phase 2]
Phase 2 trial evaluating frontline zanubrutinib plus rituximab for mucosa-associated lymphoid tissue lymphoma (MALT) is recruiting.
-
CLINICAL_TRIALS research · 2016-12-08Clinical Trial Update: Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma
A prospective study evaluating first-line Helicobacter pylori eradication for early-stage extragastric mucosa-associated lymphoid tissue lym…
-
CLINICAL_TRIALS research · 2010-09-28Clinical Trial Update: Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type [Phase 2]
Phase 2 clinical trial evaluating lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma; current trial status is unknown.